Indosat Tbk. vs Merck Tbk. — how do they compare? Indosat Tbk. trades at Rp1,885 (market cap 61.12T, 16.17M 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Indosat Tbk. is far larger — about 36× Merck Tbk.'s market cap, and Indosat Tbk. is more actively traded (16.17M versus 37.6K). Which is the better fit depends on your goals.
| ISAT | MERK | |
|---|---|---|
Market Cap | 61.12T | 1.7T |
Volume | 16.17M | 37.6K |
Lot | 161.66K | 376 |
Turnover | 30.64B | 144.47M |
Average Price | 1,895.38 | 3,842.23 |
Value | 30.64B | 144.47M |
Indicative Equilibrium Price | 1,885 | 3,840 |
Indicative Equilibrium Volume | 18.21K | 7 |
Trailing returns across standard periods
Latest headlines on both assets
Indonesian Satellite Corporation Tbk, PT (Persero), was established on November 10, 1967 within the framework of the Indonesian foreign Investment Law No. 1 of 1967. The company’s articles of association have been amended from time to time, most recently on Sept 4, 1997, concerning the changes in the articles of association to conform with Law No. 1 of 1995 on limited liability companies.
Read more on ISAT →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →